Skip to main content
SpringerLink
Log in

Controlling Clostridium difficile Infection and the Role of Antibiotic Stewardship

  • Chapter
  • First Online:
Antibiotic Policies

  • 1806 Accesses

Abstract

Since 2002, increasing rates of nosocomial Clostridium difficile infection (CDI) with a more severe course, higher mortality, and more complications have been reported in Canada, USA and Europe. One specific strain (PCR ribotype 027, REA-group BI, PFGE-type NAP1) was identified and accounted for at least half of the isolates. CDI can be prevented by robust infection control practice and prudent antibiotic use. In an outbreak setting it is often practical to combine multiple different CDI interventions which may consist of increased and early case finding, expanded infection-control measures, and antibiotic stewardship. Antimicrobials to be targeted ideally should be based on the local epidemiology and the C. difficile strains present, but restricting the use of cephalosporins and clindamycin have been the most effective. The results of fluoroquinolone restriction have been varied and may be of particular importance for outbreaks associated with the hyper-virulent PCR ribotype 027 strains.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barbut F, Mastrantonio P, Delmée M, et al (2007) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13: 1048-57.

    Article  PubMed  CAS  Google Scholar 

  • Bartlett JG (2002) Clostridium difficile-associated Enteric Disease. Curr Infect Dis Rep 4:477-48

    Article  PubMed  Google Scholar 

  • Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ (2011) ECDIS Study Group.Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759):63-73.

    Google Scholar 

  • Best EL, Fawley WN, Parnell P, et al. (2010) The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis 50: 1450-7

    Article  PubMed  Google Scholar 

  • Biller P, Shank B, Lind L, et al (2007) Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol 28:198-201

    Article  PubMed  Google Scholar 

  • Birgand G, Miliani K, Carbonne A, Astagneau P (2010) Is high consumption of antibiotics associated with Clostridium difficile polymerase chain reaction-ribotype 027 infections in France? Infect Control Hosp Epidemiol. 31: 302-5

    Article  PubMed  Google Scholar 

  • Debast SB, Vaessen N, Choudry A, et al (2009). Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect 15: 427-34

    Article  PubMed  CAS  Google Scholar 

  • Cohen SH, Gerding DN, Johnson S, et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-55

    Article  PubMed  Google Scholar 

  • Davey P, Brown E, Fenelon L, et al (2005) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev : CD003543.

    Google Scholar 

  • Dubberke ER, Reske AR, Yan Y, et al. (2007a) Clostridium difficile–Associated Disease in a Setting of Endemicity: Identification of Novel Risk Factors. Clin Infec Dis 45: 1543-9

    Article  Google Scholar 

  • Dubberke ER,Reske KA, McDonald LC, Fraser VJ (2007b) Evaluation of “CDAD pressure” as a risk factor for Clostridium difficile-associated disease. Arch Intern Med 167: 1092–7

    Article  Google Scholar 

  • Freeman J, Bauer MP, Baines SD, et al (2010) The Changing Epidemiology of Clostridium difficile Infection. Clin Microbiol Rev in press

    Google Scholar 

  • Gaynes R, Rimland D, Killum E, et al (2004) Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38:640-5

    Article  PubMed  Google Scholar 

  • Goorhuis AT, Van der Kooi T, Vaessen N, et al (2007) Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45: 695-703

    Article  PubMed  CAS  Google Scholar 

  • Goorhuis A, Bakker D, Corver J, et al. (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47: 1162-70

    Article  PubMed  CAS  Google Scholar 

  • He M, Sebaihia M, Lawley TD, Stabler R, et al (2010) Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A. 107: 7527-32

    Article  PubMed  CAS  Google Scholar 

  • Hensgens MP, Goorhuis A, Notermans DW, et al (2009) Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 14; pii: 19402

    Google Scholar 

  • Hensgens MP, Goorhuis A, Notermans DW, et al. (2010) Veranderingen in 2008/’09 van de epidemiologie van Clostridium difficile infecties in Nederland. Ned Tijdschr Geneeskd 154: 1142-6

    Google Scholar 

  • Hensgens MP, Goorhuis A, van Kinschot CM, Crobach MJ, Harmanus C, Kuijper EJ (2011) Clostridium difficile infection in an endemic setting in the Netherlands. Eur J Clin Microbiol Infect Dis 30:587-93

    Google Scholar 

  • Johnson S, Samore MH, Farrow KA, et al (1999) Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 341:1645-51

    Article  PubMed  CAS  Google Scholar 

  • Kaier K, Luft D, Dettenkofer M, et al (2010) Correlations between bed occupancy rates and Clostridium difficile infections: a time-series analysis. Epidemiol Infect. [Epub ahead of print]

    Google Scholar 

  • Kallen AJ, Thompson A, Ristaino P, et al (2009) Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infection Control and Hospital Epidemiology 30:264-72.

    Article  PubMed  Google Scholar 

  • Kuijper EJ, van Dissel JT, Wilcox MH (2007) Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 20: 376-83

    PubMed  Google Scholar 

  • Kuijper EJ, van den Berg RJ, Brazier JS (2009) Comparison of molecular typing methods applied to Clostridium difficile. Methods Mol Biol 551: 159-71

    Article  PubMed  CAS  Google Scholar 

  • Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12 Suppl 6:2-18

    Google Scholar 

  • Kuijper EJ, Barbut F, Brazier JS, et al (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13; pii: 18942

    Google Scholar 

  • Loo VG, Poirier L, Miller MA, et al (2005) A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442–9

    Article  PubMed  CAS  Google Scholar 

  • Merrigan M, Sambol S, Johnson S, Gerding DN (2003) Susceptibility of hamsters to hamster pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration. Anaerobe 9:91-5.

    Article  PubMed  CAS  Google Scholar 

  • Muto CA, Blank MK, Marsh JW, et al (2007) Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis 45: 1266-73

    Article  PubMed  Google Scholar 

  • McDonald LC, Killgore GE, Thompson A, et al (2005) An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353: 2433–41

    Article  PubMed  CAS  Google Scholar 

  • Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can Med Assoc J 173: 1037–42.

    Article  Google Scholar 

  • Popoff MR, Rubin EJ, Gill DM, Boquet P (1988) Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56: 2299-306

    PubMed  CAS  Google Scholar 

  • Riggs MM, Sethi AK, Zabarsky TF, et al (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45: 992–998

    Article  PubMed  Google Scholar 

  • Roberts K, Smith CF, Snelling AM, et al. (2008) Aerial dissemination of Clostridium difficile spores. BMC Infect Dis 8: 7

    Article  PubMed  Google Scholar 

  • Spigaglia P, Barbanti F, Louie T, et al. (2009) Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrob Agents Chemother 53: 2463-8.

    Article  PubMed  CAS  Google Scholar 

  • Salgado CD, Mauldin PD, Fogle PJ, Bosso JA (2009) Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures. Am J Infect Control 37: 458-64.

    Article  PubMed  Google Scholar 

  • Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ (2010) Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 31: 21-7

    Article  PubMed  Google Scholar 

  • Valiquette L, Cossette B, Garant MP, Diab H, Pepin J (2007) Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 45(Suppl 2): S112–21.

    Article  PubMed  CAS  Google Scholar 

  • van Nood E, Speelman P, Kuijper EJ, et al (2009). Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill 14 pii: 19316.

    Google Scholar 

  • van der Kooi TI, Koningstein M, Lindemans A, et al (2008) Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol 57:709-16

    Article  PubMed  Google Scholar 

  • van der Kooi TI, Manniën J, Wille JC, van Benthem BH (2010) Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. J Hosp Infect 2010 Epub ahead of print

    Google Scholar 

  • Vonberg RP, Kuijper EJ, Wilcox MH, et al (2008) Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect Suppl 5:2-20

    Article  Google Scholar 

  • Zoetendal EG, Rajilic-Stojanovic M, de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57: 1605-15

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA, Leiden, The Netherlands

    Ed J. Kuijper & A. Goorhuis

  2. Departments of Research and Medicine, Hines Veterans Affairs Hospital and Loyola University Medical Center, Chicago, IL, USA

    S. Johnson

  3. Department of Microbiology, Old Medical School, Leeds General Infirmary, Leeds, UK

    M. H. Wilcox

Authors
  1. Ed J. Kuijper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Goorhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. H. Wilcox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ed J. Kuijper .

Editor information

Editors and Affiliations

  1. Medical School, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom

    Ian M. Gould

  2. University Hospital Nijmegen, Nijmegen, Netherlands

    Jos W.M. van der Meer

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kuijper, E.J., Johnson, S., Goorhuis, A., Wilcox, M.H. (2012). Controlling Clostridium difficile Infection and the Role of Antibiotic Stewardship. In: Gould, I., van der Meer, J. (eds) Antibiotic Policies. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1734-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1734-8_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1733-1

  • Online ISBN: 978-1-4419-1734-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation